Remedy Entertainment Oyj
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RMDEF research report →
Price Chart
About the company
Remedy Entertainment Oyj is a Finnish video game developer and publisher that creates and markets computer and console games to audiences both within Finland and internationally. The company is primarily recognized for its focus on crafting action titles that feature compelling narratives and exceptional visual fidelity. Established in Espoo, Finland, in 1995, it has been a presence in the gaming industry for decades.
- CEO
- Jean-Charles Gaudechon
- IPO
- 2022
- Employees
- 387
- HQ
- Espoo, UU, FI
Get TickerSpark's AI analysis on RMDEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $210.65M
- P/E
- -102.24
- Fwd P/E
- 77.59
- PEG
- 0.58
- P/S
- 5.86
- P/B
- 4.30
- EV/EBITDA
- 118.56
- Div Yield
- 0.00%
- Gross Margin
- 87.44%
- Op Margin
- -5.43%
- Net Margin
- -5.87%
- ROE
- -4.25%
- ROIC
- -2.98%
Latest fiscal year · YoY change
- Revenue
- $59.51M+17.5%
- Gross Profit
- $47.27M+38.6%
- Op Income
- $-14,863,000
- Net Income
- $-13,030,000-262.3%
- EPS
- $-0.96-255.6%
- OCF Growth
- -63.2%
- FCF Growth
- -87.9%
- 52W High
- $18.37
- 52W Low
- $15.13
- 50D MA
- $15.37
- 200D MA
- $16.27
- Beta
- 1.06
- RSI (14)
- 98
- Avg Volume
- 5
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Remedy reported a weaker Q2 on revenue and profitability as CONTROL Resonant marketing ramped, while launch momentum and full-year guidance remained intact ahead of the September 24 release.· August 11, 2026
- Revenue was EUR 10.2 million, down 40% year over year, with EBITDA at minus EUR 2.4 million and EBIT at minus EUR 3.9 million.
- Management said the Q2 decline was driven mainly by the prior-year Firebreak launch accruals and higher CONTROL Resonant marketing spend.
- CONTROL Resonant launches worldwide on September 24, with management highlighting strong early interest: over 1.5 million wishlists, top-preorder placement on PlayStation in the U.S., Germany and Brazil, and positive hands-on feedback.
- Alan Wake 2 passed 3 million lifetime copies sold, while CONTROL surpassed 6 million copies sold and 20 million lifetime players.
- Full-year outlook was unchanged: revenue and EBITDA are still expected to increase versus the previous year.
Q2 2026 revenue was EUR 10.2 million, down 40% year over year. EBITDA was minus EUR 2.4 million and EBIT was minus EUR 3.9 million. Operating cash flow was negative EUR 0.7 million. Santtu Kallionpaa said cash at the end of June 2026 was EUR 29.6 million, including EUR 9.6 million in cash and EUR 20 million in short-term cash management investments. He also said year-to-date revenue was EUR 23.3 million, first-half EBITDA was 2.3% positive, and first-half EBIT was 12.5% negative. Forward guidance was limited, but management said the full-year outlook is unchanged and they expect revenue and EBITDA to increase from the previous year; they also said marketing costs should be higher in the second half than in the first half, with the peak around the launch window.
Jean-Charles Gaudechon framed the quarter around CONTROL Resonant’s global launch preparations, emphasizing that the game is Remedy’s most ambitious self-published release to date. He said early previews, hands-on demos, and market response have been very encouraging, especially the positive reaction to the faster melee-oriented gameplay, localization, and atmosphere. His tone was upbeat and confident, but he repeatedly noted that previews are not reviews and that launch execution still matters.
Santtu Kallionpaa focused on accounting treatment and the cash impact of self-publishing. He explained that preorder revenue is not recognized until launch under IFRS, that Q2 had no cash-flow impact from preorders because platform payments usually lag by at least a month, and that cash flow from operations was negative EUR 0.7 million mainly because of the low revenue level. He also said cash flow from investments was minus EUR 3.8 million due to capitalized development, especially CONTROL Resonant, and highlighted EUR 3.7 million of capitalized development expenses, EUR 2.6 million of external work expenses, and EUR 9 million of personnel expenses.
Analysts focused heavily on CONTROL Resonant’s commercial indicators, including wishlists, preorders, platform split, China reception, and marketing spend. Management said the 1.5 million wishlists are net of cancellations and cumulative, that preorders are positive and tracking ahead of some prior games, and that interest is strong across platforms and especially encouraging in Chinese-speaking markets. They also said the second half of the year will have higher marketing costs than the first half, with the peak around launch, and that the marketing budget is flexible if reception warrants it.
The bull case from the call is that CONTROL Resonant appears to be landing well ahead of launch, with strong wishlist and preorder traction, positive preview coverage, and early signs of broad international demand. Remedy also pointed to long-term franchise strength in CONTROL, continued sales from Alan Wake 2, and a self-publishing model that could improve economics after recoupment.
The bear case is that Q2 revenue and profitability were both down sharply, with only EUR 10.2 million of revenue and negative EBITDA/EBIT, and management expects marketing spend to rise further into the launch quarter. There is also execution risk around a busy September release window, and management stressed that wishlists and preview sentiment do not guarantee final sales conversion.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 58.7%
- Shares Outstanding
- 13.59M
- Float Shares
- 7.98M
Our RMDEF coverage
Recent articles, reports, and earnings notes.
No research on RMDEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RMDEF report →Remedy Entertainment Oyj (RMDEF) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 11
Remedy Entertainment Oyj (RMDEF) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 5
Remedy Entertainment Oyj (RMDEF) Q4 2025 Earnings Call Transcript
seekingalpha.com · Feb 16
Remedy Entertainment Oyj (RMDEF) Q3 2025 Earnings Call Transcript
seekingalpha.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.